Mcpt4 Antibody

What is Mcpt4 and why is it important in immunological research?

Mcpt4 (mast cell protease 4) is a serine protease primarily expressed in mast cells of mice and rats. It is functionally homologous to human chymase and has chymotrypsin-like enzymatic activity, hydrolyzing amide bonds between tyrosine and phenylalanine residues. The significance of Mcpt4 in immunological research stems from its multiple biological roles, including regulation of intestinal epithelial cell migration and barrier function, participation in extravascular coagulation, and modulation of immune responses during infection and inflammation . Particularly, Mcpt4 has been shown to suppress type-1 immune responses while promoting type-2 responses during Plasmodium infection, making it a valuable target for studying immune regulation mechanisms during parasitic infections and inflammatory conditions . Understanding Mcpt4 function provides insights into mast cell-mediated processes that are relevant to human pathophysiology.

How does Mcpt4 affect intestinal barrier function and immunity?

Mcpt4 plays a critical role in maintaining intestinal epithelial barrier integrity. Research using Mcpt4-/- knockout mice has demonstrated that Mcpt4 deficiency is associated with altered intestinal permeability during Plasmodium infection . When challenged with P. y. yoelii 17XNL infection, Mcpt4-/- mice exhibit increased intestinal permeability to FITC-dextran and altered ileal adherens junction E-cadherin compared to Mcpt4+/+ controls . Additionally, Mcpt4 affects the timing and magnitude of mast cell accumulation in the intestine, with Mcpt4-/- mice showing earlier ileal mast cell accumulation during malaria infection . The absence of Mcpt4 shifts the immune response toward a type-1 profile with elevated TNF-α, IL-12p40, and IL-3, whereas Mcpt4+/+ mice develop a predominant type-2 response characterized by increased IL-2, IL-10, and MIP1β (CCL4) . These findings suggest that Mcpt4 orchestrates both intestinal barrier function and systemic immune responses, particularly during infectious challenges.

What are the functional differences between Mcpt4 and other mast cell proteases?

Mcpt4 belongs to the family of mast cell chymases but exhibits distinct functional properties compared to other mast cell proteases such as Mcpt1 (tryptase). While both are serine proteases secreted by activated mast cells, they differ in substrate specificity, tissue distribution, and physiological roles:

Research reveals that Mcpt4 deficiency does not affect the expression or function of Mcpt1, as demonstrated by equivalent levels of Mcpt1-positive cells in both Mcpt4-/- and wild-type mice . Furthermore, IgE-mediated passive anaphylaxis experiments show that Mcpt4-/- mice maintain normal mast cell functionality and Mcpt1 secretion, indicating no global defect in mast cell degranulation or protease secretion in Mcpt4-/- animals . This functional independence allows researchers to specifically study Mcpt4-dependent processes using knockout models.

What are the common applications of Mcpt4 antibodies in research?

Mcpt4 antibodies are versatile immunological tools employed in multiple research applications:

• Immunohistochemistry (IHC): Mcpt4 antibodies enable detection and localization of mast cells in tissue sections, particularly in mouse and rat models. They can be used to evaluate mast cell distribution patterns, especially at the villus/crypt junctions where Mcpt4-positive cells are predominantly found .

• Western Blotting: Researchers utilize Mcpt4 antibodies to quantify protein expression levels in tissue or cell lysates, allowing assessment of changes in Mcpt4 expression during disease progression or in response to experimental interventions .

• ELISA: Mcpt4 antibodies are employed in enzyme-linked immunosorbent assays to measure secreted Mcpt4 in biological fluids like plasma or serum, serving as a biomarker of mast cell activation .

• Flow Cytometry: Though less common than other applications, specialized Mcpt4 antibodies can be used in flow cytometric analysis of permeabilized cells to identify and quantify Mcpt4-expressing mast cells .

• Validation of Knockout Models: Mcpt4 antibodies are essential for confirming the absence of Mcpt4 protein expression in Mcpt4-/- knockout mice used in experimental studies .

When selecting Mcpt4 antibodies, researchers should consider factors such as species reactivity (typically mouse or rat-specific), clonality (monoclonal vs. polyclonal), and conjugation status, which should align with the specific requirements of their experimental design .

What are the optimal protocols for detecting Mcpt4 in tissue samples?

Successful detection of Mcpt4 in tissue samples requires careful consideration of fixation, antibody selection, and visualization methods. Based on published research protocols, the following optimized procedure is recommended:

Tissue Preparation and Fixation:

• Fix freshly collected tissue samples in 4% paraformaldehyde for 24 hours

• Process tissues through graded alcohols and embed in paraffin

• Section tissues at 4 μm thickness using a microtome

• Mount sections on positively charged slides

Immunohistochemistry Protocol:

• Deparaffinize sections through xylene and graded alcohols

• Perform antigen retrieval using citrate buffer (pH 6.0) at 95°C for 20 minutes

• Block endogenous peroxidase with 3% H₂O₂ for 10 minutes

• Apply protein block (5% normal serum) for 30 minutes

• Incubate with primary anti-Mcpt4 antibody (1:100-1:300 dilution) at 4°C overnight

• Wash with PBS (3 × 5 minutes)

• Apply HRP-conjugated secondary antibody for 30 minutes at room temperature

• Visualize using DAB substrate

• Counterstain with hematoxylin

• Dehydrate, clear, and mount with permanent mounting medium

Alternative Staining Method:
For rapid identification of mast cells containing chymase activity, toluidine blue staining can be used as complementary to immunohistochemistry . This metachromatic stain allows visualization of mast cell granules containing proteases including Mcpt4.

For optimal results, researchers should validate antibody specificity using appropriate controls, including tissues from Mcpt4-/- mice, which should show no positive staining for Mcpt4 .

How can Mcpt4 antibodies be validated for specificity in experimental models?

Ensuring antibody specificity is critical for obtaining reliable research results. The following comprehensive validation approaches should be implemented when working with Mcpt4 antibodies:

Genetic Validation:

• Knockout Control: The gold standard for antibody validation is testing on tissues from Mcpt4-/- mice. These samples should show complete absence of staining when proper controls are employed .

• Sibling-Matched Controls: Compare staining patterns between Mcpt4+/+ and Mcpt4-/- littermates to minimize genetic background variability.

Technical Validation:

• Antibody Titration: Perform serial dilutions of the primary antibody to determine optimal signal-to-noise ratio.

• Isotype Controls: Include appropriate isotype-matched control antibodies to assess non-specific binding.

• Secondary-Only Controls: Omit primary antibody to evaluate background from secondary antibody.

• Peptide Competition: Pre-incubate primary antibody with excess Mcpt4 peptide antigen to confirm signal specificity.

Functional Validation:

• Correlation with Function: Assess whether Mcpt4 detection correlates with known functional outcomes, such as changes in intestinal permeability or immune response profiles .

• Multi-technique Confirmation: Confirm findings using alternative detection methods (e.g., if using IHC, verify with Western blot or qPCR).

Research has demonstrated that proper validation reveals distinct staining patterns in wild-type mice, with Mcpt4-positive cells primarily localized to the villus/crypt junction, while no positive cells are found in Mcpt4-/- mice tissues under identical staining conditions .

What methods are effective for analyzing Mcpt4's role in immune modulation?

Investigating Mcpt4's immunomodulatory functions requires integrated approaches that combine molecular, cellular, and functional analyses:

Infection Models and Immune Response Analysis:

• Parasite Challenge: Using models such as P. y. yoelii 17XNL infection in Mcpt4-/- and Mcpt4+/+ mice allows assessment of Mcpt4's role in pathogen clearance and immune regulation .

• Cytokine Profiling: Multiplex cytokine assays of plasma samples at defined timepoints (days 4, 6, 8, and 10 post-infection) reveal Mcpt4-dependent shifts in immune response. Key analytes should include TNF-α, IL-12p40, IL-3 (type-1 response) and IL-2, IL-10, and MIP1β/CCL4 (type-2 response) .

Correlation Analysis:
Network analysis using Cytoscape software can identify significant Spearman correlations between parasitemia, bacterial load (16S DNA copies), and immune factors, with parasitemia and 16S copies as main targets and mast cells and immune factors as sources . This approach has revealed that early (day 4 PI) correlation of parasitemia with TNF-α and IFN-γ occurs in Mcpt4-/- mice but is delayed until day 10 PI in Mcpt4+/+ mice .

Intestinal Barrier Assessment:

• FITC-Dextran Permeability: Oral administration of FITC-dextran followed by plasma fluorescence measurement quantifies intestinal permeability changes in the presence or absence of Mcpt4 .

• Adherens Junction Integrity: Immunofluorescence analysis of E-cadherin and ZO-1 in ileal tissues reveals Mcpt4-dependent alterations in epithelial junction integrity .

These integrated approaches have demonstrated that Mcpt4 suppresses early type-1 immune responses while promoting type-2 immunity and protecting epithelial barrier integrity during Plasmodium infection .

How does Mcpt4 influence parasitemia and transmission in malaria models?

Research using Mcpt4 knockout models has revealed complex roles for this protease in malaria infection dynamics and transmission. Studies with P. y. yoelii 17XNL-infected mice demonstrated several key findings:

Parasitemia Control:
Mcpt4-/- mice exhibit significantly lower parasitemia compared to Mcpt4+/+ controls by day 10 post-infection, indicating that Mcpt4 actually suppresses parasite clearance mechanisms . This unexpected finding suggests that mast cell chymase activity may benefit the parasite rather than the host during the acute phase of infection.

Immune Response Regulation:
The mechanism behind reduced parasitemia in Mcpt4-/- mice appears to involve enhanced type-1 immune responses. Mcpt4-/- mice show early increased plasma levels of TNF-α, IL-12p40, and IL-3, while Mcpt4+/+ mice exhibit elevated IL-2, IL-10, and MIP1β (CCL4) . Spearman correlation analysis revealed that in Mcpt4-/- mice, parasitemia correlated with TNF-α and IFN-γ (known for their roles in pathogen clearance) at day 4 post-infection, whereas this correlation was delayed until day 10 in Mcpt4+/+ mice .

Transmission Dynamics:
Intriguingly, transmission success of P. y. yoelii 17XNL to Anopheles stephensi mosquitoes was significantly higher from infected Mcpt4-/- mice compared to infected Mcpt4+/+ mice . This finding indicates that while Mcpt4 may suppress parasite clearance within the mammalian host, it paradoxically reduces the transmissibility of sexual stage parasites to mosquito vectors.

These findings suggest that Mcpt4 orchestrates a delicate balance in host-parasite interactions, potentially representing an evolutionary compromise between acute infection control and transmission limitation. The enhanced understanding of Mcpt4's role in malaria pathogenesis could inform future therapeutic approaches targeting mast cell function during parasitic infections.

What are the methodological considerations for studying Mcpt4 in intestinal barrier function?

Investigating Mcpt4's role in intestinal epithelial barrier regulation requires specialized techniques addressing both structural and functional aspects of barrier integrity:

Experimental Models:

• Genetic Models: Mcpt4-/- mice on C57BL/6J background compared with Mcpt4+/+ controls provide the foundation for studying Mcpt4-specific effects on intestinal barrier function .

• Challenge Models: Infection with P. y. yoelii 17XNL (1 × 10^6 parasites) or other intestinal barrier stressors can be used to induce barrier dysfunction and reveal Mcpt4-dependent effects .

Barrier Function Assessment:

• In vivo permeability assays: Oral administration of 4kDa FITC-dextran (500 mg/kg) followed by blood collection at 4 hours post-administration. Plasma fluorescence should be measured at excitation 485nm and emission 528nm to quantify intestinal permeability .

• Junction protein analysis: Immunofluorescence staining of E-cadherin (adherens junctions) and ZO-1 (tight junctions) with quantification of fluorescence intensity using standardized imaging parameters .

Mast Cell Evaluation:

• Quantification: Count toluidine blue-positive or anti-Mcpt1-stained mast cells per high-power field (HPF) in the ileum at various timepoints (days 4, 6, 8, and 10 post-challenge) .

• Activation assessment: Measure plasma levels of mast cell proteases (Mcpt1) using ELISA as indicators of mast cell activation .

Data Analysis Approaches:
The Kruskal-Wallis test followed by Dunn's multiple comparison of infected versus uninfected controls or Mcpt4-/- versus Mcpt4+/+ mice at different timepoints provides statistical rigor for analyzing changes in barrier function parameters .

Research using these approaches has demonstrated that Mcpt4 plays a protective role in maintaining intestinal barrier integrity during Plasmodium infection, with Mcpt4-/- mice showing increased permeability to FITC-dextran and altered E-cadherin distribution despite experiencing lower parasitemia .

How can multiplex approaches enhance Mcpt4 research in inflammatory contexts?

Advanced multiplex methodologies enable comprehensive characterization of Mcpt4's role within complex inflammatory networks:

Multiplex Immunohistochemistry:
Multiplex IHC allows simultaneous detection of Mcpt4 alongside other markers, providing spatial context for Mcpt4-expressing cells relative to other immune populations and structural elements:

• Protocol Optimization: For successful multiplex staining including Mcpt4:

  • Use tyramide signal amplification (TSA) systems for sequential staining

  • Perform heat-mediated antigen retrieval between antibody applications

  • Include anti-MC tryptase (1:100) alongside Mcpt4 antibodies to differentiate mast cell subpopulations

• Analysis Approach: Quantify co-localization of markers using digital pathology software with cell segmentation capabilities to determine the percentage of Mcpt4+ cells expressing additional functional markers .

Cytokine Network Analysis:

• Multiplex Cytokine Profiling: Simultaneously assess up to 32 cytokines/chemokines in plasma samples from Mcpt4-/- and Mcpt4+/+ mice under various conditions using bead-based multiplex platforms .

• Network Visualization: Construct interaction networks using Cytoscape software (version 3.8.2) based on significant Spearman correlation coefficients (P ≤ 0.05) with parasitemia and bacterial load as main targets and Mcpt4 and immune factors as sources .

• Selection Criteria: Include immune factors with fold-change >1.5 relative to uninfected control in network visualization analyses to focus on biologically significant interactions .

This integrated approach has revealed that Mcpt4 deficiency shifts the immune network toward early type-1 responses (TNF-α, IL-12p40, IFN-γ) while wild-type mice exhibit predominant type-2 responses (IL-2, IL-10, CCL4) , providing insights into Mcpt4's role as an immunomodulatory switch during inflammatory challenges.

How should researchers quantify and interpret Mcpt4-positive cell distribution?

Accurate quantification of Mcpt4-positive cells is essential for meaningful interpretation of experimental results. A standardized approach should include:

Quantification Methodology:

• Systematic Sampling: Analyze at least 5-10 non-overlapping high-power fields (HPF, 400×) per tissue section, with 3-5 sections per sample separated by at least 100 μm to ensure representative sampling .

• Cell Counting: Count all Mcpt4-positive cells meeting these criteria:

  • Distinct cellular morphology with visible nucleus

  • Clear membrane/cytoplasmic staining pattern

  • Signal intensity above background threshold

• Normalization: Express results as:

  • Mcpt4+ cells per mm² (preferred for absolute quantification)

  • Mcpt4+ cells per HPF (for relative comparisons)

  • Mcpt4+ cells per crypt or per villus (for intestinal tissue specifically)

Interpretation Guidelines:

• Distribution Patterns: In normal intestinal tissue, Mcpt4+ cells localize primarily to the villus/crypt junctions, with fewer cells in the villus proper or submucosa . Altered distribution patterns (e.g., increased intraepithelial localization) may indicate pathological processes.

• Comparison with Other Markers: When analyzing Mcpt4-/- mice, researchers should also quantify other mast cell markers (e.g., Mcpt1) to distinguish Mcpt4-specific effects from general changes in mast cell populations .

• Temporal Dynamics: In infection models, compare Mcpt4+ cell numbers at multiple timepoints (e.g., days 4, 6, 8, and 10 post-infection) to capture dynamic changes in mast cell recruitment and activation .

Research has shown that while Mcpt4-/- and wild-type mice exhibit no significant difference in baseline intestinal mast cell numbers or distribution, they differ in temporal dynamics during infection, with Mcpt4-/- mice showing earlier mast cell accumulation in response to Plasmodium infection . These findings highlight the importance of temporal analysis in understanding Mcpt4's role in mast cell biology.

What are the best approaches for resolving contradictory findings in Mcpt4 research?

Contradictory findings regarding Mcpt4's biological roles can arise from methodological differences, context-dependent functions, or complex interactions with other pathways. Researchers can address these contradictions through systematic approaches:

Sources of Contradiction:

• Model-Dependent Effects: Mcpt4 may have different or even opposing roles depending on the disease model. For instance, while Mcpt4 protects against G. intestinalis-induced pathology, it appears to suppress host immune responses to P. y. yoelii 17XNL .

• Temporal Considerations: Effects may vary based on disease stage. In malaria models, early vs. late immune responses show distinct Mcpt4-dependent patterns .

• Compensatory Mechanisms: In Mcpt4-/- mice, other proteases or pathways may compensate for Mcpt4 deficiency, potentially masking or altering phenotypes .

Resolution Strategies:

• Comprehensive Phenotyping: Analyze multiple parameters (e.g., parasitemia, intestinal permeability, immune responses) in parallel to capture the full spectrum of Mcpt4-dependent effects .

• Time-Course Studies: Examine outcomes at multiple timepoints to capture dynamic changes and potential biphasic effects .

• Multi-Model Validation: Test hypotheses across different disease models to determine context-specific vs. universal functions of Mcpt4.

• Network Analysis: Employ statistical approaches such as Spearman correlation with network visualization to identify complex relationships between Mcpt4 and other factors .

When applying these strategies, researchers have resolved apparent contradictions in Mcpt4 function during malaria infection. For example, while Mcpt4 deficiency reduces parasitemia (suggesting a protective effect of Mcpt4 loss), it also increases intestinal permeability (suggesting a protective effect of Mcpt4 presence) . Network analysis revealed that these seemingly contradictory findings reflect Mcpt4's dual role in suppressing anti-parasite immunity while maintaining intestinal barrier integrity .

How can researchers correlate Mcpt4 expression with disease progression markers?

Effective correlation analysis between Mcpt4 expression and disease markers requires robust statistical approaches and comprehensive data collection:

Data Collection Framework:

• Longitudinal Sampling: Collect samples at defined intervals throughout disease progression (e.g., days 4, 6, 8, and 10 post-infection in malaria models) .

• Multi-Parameter Assessment:

  • Mcpt4 expression (protein levels via ELISA or Western blot)

  • Disease-specific parameters (e.g., parasitemia in malaria models)

  • Relevant immune markers (cytokines, chemokines)

  • Functional outcomes (intestinal permeability, clinical scores)

Statistical Analysis Approaches:

Interpretation Framework:
When applying these approaches to malaria models, researchers discovered that early (day 4 PI) correlation of parasitemia with TNF-α and IFN-γ occurred in Mcpt4-/- mice but was delayed until day 10 PI in Mcpt4+/+ mice . This finding suggests that Mcpt4 temporally regulates the relationship between parasite burden and inflammatory cytokine production, potentially by degrading TNF-α and delaying the type-1 immune response necessary for parasite clearance . Additionally, correlation analysis revealed different relationships between mast cell proteases and intestinal permeability depending on Mcpt4 status, highlighting the protease's role in maintaining gut barrier function during infection .

By systematically correlating Mcpt4 expression with multiple disease markers across timepoints, researchers can uncover complex regulatory networks and identify potential intervention points for therapeutic development.

What are the emerging applications for Mcpt4 antibodies in translational research?

The study of Mcpt4 and its human chymase ortholog presents several promising avenues for translational research:

Intestinal Barrier Regulation:
Given Mcpt4's role in maintaining intestinal epithelial integrity , therapeutic approaches targeting chymase activity could potentially address conditions characterized by barrier dysfunction. Specific applications include:

• Inflammatory Bowel Disease: Investigation of human chymase inhibitors to preserve barrier function during intestinal inflammation

• Enteric Infections: Development of treatment strategies that preserve beneficial barrier maintenance functions while enhancing pathogen clearance

Malaria Immunomodulation:
The discovery that Mcpt4 suppresses type-1 immune responses during Plasmodium infection suggests potential for targeted interventions:

• Adjuvant Approaches: Temporary chymase inhibition during vaccination to enhance type-1 immune responses and improve vaccine efficacy

• Therapeutic Modulation: Timed inhibition of chymase during malaria infection to accelerate parasite clearance while minimizing immunopathology

Cancer Research Applications:
Recent studies implicate mast cells in colorectal cancer progression . Future research could explore:

• Prognostic Biomarkers: Using chymase expression patterns to predict cancer progression or treatment response

• Therapeutic Targeting: Developing strategies to modulate chymase activity in the tumor microenvironment

To advance these translational applications, researchers will need to develop increasingly specific antibodies and small molecule inhibitors that can distinguish between beneficial and detrimental functions of Mcpt4/chymase across different disease contexts. Humanized mouse models expressing human chymase would provide valuable platforms for preclinical development of such targeted approaches.

What technological advances will enhance future studies of Mcpt4 biology?

Emerging technologies are poised to revolutionize our understanding of Mcpt4 biology and function:

Single-Cell Analysis:
Single-cell RNA sequencing and proteomics will enable unprecedented resolution of mast cell heterogeneity and Mcpt4 expression patterns:

• Subpopulation Identification: Characterization of Mcpt4-expressing mast cell subsets and their distinct functional properties

• Spatial Transcriptomics: Mapping Mcpt4 expression in relation to tissue microenvironment and neighboring cell populations

Advanced Imaging Techniques:

• Intravital Microscopy: Real-time visualization of Mcpt4+ mast cell dynamics during inflammation and immune responses

• Super-Resolution Microscopy: Nanoscale localization of Mcpt4 within mast cell granules and at sites of release

• Multiplexed Ion Beam Imaging (MIBI): Simultaneous detection of >40 proteins to contextualize Mcpt4 expression within complex tissue environments

CRISPR-Based Approaches:

• Conditional/Inducible Knockouts: Temporal and cell-specific deletion of Mcpt4 to dissect context-dependent functions

• Base Editing: Introduction of specific mutations in Mcpt4 to study structure-function relationships

• CRISPRa/CRISPRi: Modulation of Mcpt4 expression levels without complete gene deletion

Artificial Intelligence Integration:
Machine learning approaches will enhance analysis of complex datasets involving Mcpt4 function:

• Pattern Recognition: Identification of subtle Mcpt4-dependent phenotypes across multiple parameters

• Predictive Modeling: Forecasting outcomes of Mcpt4 modulation in various disease contexts

• Network Analysis: Advanced algorithms for interpreting complex interactions between Mcpt4 and other immune factors

These technological advances will enable researchers to move beyond correlative observations toward mechanistic understanding of how Mcpt4 orchestrates diverse biological processes, from intestinal barrier maintenance to immune response regulation during infectious challenges.